
KPV · 10 mg
The last three amino acids of alpha-MSH — the hormone Melanotan was built from — cut down to just the part that calms inflammation. It enters gut cells through the same transporter your body uses to absorb small protein fragments from food.
Includes 10× sterile insulin syringes + 1 vial of bacteriostatic water, free with your order.
Complete your kit
For research and educational use only. Not for human or veterinary consumption.
What has been shown, in animals and cells:
- It calmed colitis in mice. Across several models, KPV led to faster recovery, regained body weight, and less inflammation in the colon wall. In several of the key studies it was given by mouth.
- It's absorbed by the gut's own peptide transporter. PepT1 normally sits in the small intestine but appears in the colon when it's inflamed — which means KPV gets pulled into exactly the cells that are inflamed.
- It switches off a master inflammation signal. KPV stops NF-κB reaching the cell nucleus, cutting the cytokines that drive gut and airway inflammation in human cell studies.
- Topical and skin work — less inflammation and cell death in human skin cells, faster healing of mouth ulcers in rats, and antimicrobial activity against Staph aureus and Candida in the lab.
What people using it report:
- Gut first: less bloating, less cramping and more regular stools, usually after 2–4 weeks. IBS-type symptoms and gut inflammation are by far the most common reason people buy it.
- Skin second: fewer flare-ups of eczema- or psoriasis-type patches over 4–6 weeks
- Histamine and mast-cell issues — a popular use in online communities. Be aware there is no published research at all on KPV and mast cells. That use is pure extrapolation.
- Commonly paired with BP-157 for the gut — the combination in our Gut & Immunity package
It has never been tested in a human being. Not one trial, not one pharmacokinetic study. In July 2026 the FDA's own reviewers found no human data for KPV by any route. Everything above is mice, rats and cells in a dish.
It does not treat Crohn's disease or ulcerative colitis. If you have a diagnosed inflammatory bowel disease, this is not a substitute for your treatment — and never stop a prescribed medicine to try it.
Injecting it is a community convention, not something the gut research tested. Several of the key colitis studies gave KPV by mouth, which uses the gut's transporter to reach the inflamed lining directly. Nobody knows whether an injection reaches the gut wall in the same way, or how much.
It will not tan you or raise libido. KPV doesn't act on the melanocortin receptors that Melanotan uses — it shares the parent hormone, not the effects.
Common: injection site redness, itching or a small bump.
Reported by users: mild, temporary gut changes in the first week — looser stools or some bloating — usually settling on their own.
Unknown: KPV has no characterised human safety profile. No toxicity, reproduction or long-term studies exist, and the FDA notes that short peptides can trigger immune reactions. We'd rather tell you that than list side effects nobody has measured.
Stop and see a doctor:
- Blood in your stool, fever, severe abdominal pain, or diarrhoea six or more times a day — these are signs of a real flare that needs medical treatment, not a peptide
- Signs of dehydration — dizziness, very dark urine, unable to keep fluids down
- Hives, swelling of the face or throat, or difficulty breathing after an injection
🛑 Don't use it if you're pregnant or breastfeeding, or without your doctor's agreement if you take immunosuppressants or biologics for any condition.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
10 mg vial + 2 mL bacteriostatic water = 5 mg/mL
| Dose | Volume | Units (U-100) |
|---|---|---|
| 250 mcg | 0.05 mL | 5 |
| 500 mcg | 0.10 mL | 10 |
| 1 mg | 0.20 mL | 20 |
Inject the water slowly down the inside wall of the vial. Swirl gently, never shake. It should dissolve to a clear solution. Refrigerate at 2–8 °C and use within 4 weeks.
Draw past the line, tap out bubbles, push back to the line.
The AVERON Peptide Pen delivers 1 click = 0.01 mL. A U-100 insulin syringe delivers 1 unit = 0.01 mL. They are the same number. 20 clicks on the pen and 20 units on a syringe deliver exactly the same dose.
Maximum per injection: 100 units (1 mL)
500 mcg (10 clicks) once daily, subcutaneous. Abdomen is the usual site for gut-focused use, rotating spots. Starting at 250 mcg (5 clicks) for the first three days lets you see how you react.
Cycle: 8 weeks, then a break of at least 4 weeks.
Honest vial arithmetic: at 500 mcg every day, one vial lasts 20 days. An 8-week cycle uses 28 mg — that's 3 vials, not 2.
✅ Want each vial to last its full 4-week fridge window? Run 500 mcg 5 days on, 2 days off. That's 2.5 mg a week — one vial is exactly 4 weeks, and two vials cover a full 8-week cycle.
Some people take KPV by mouth for gut use, which is how several of the key mouse studies gave it. There is no human data on any route or any dose. The 200–500 mcg range everyone quotes is community convention, not a proven human dose.
- 1× KPV · 10 mg
- 10× sterile insulin syringes (free)
- 1× bacteriostatic water vial (free)
- Compound Guide — printed, included free
Animal and cell data only. No human clinical trial of KPV has ever been completed or published. The strongest work is a consistent set of mouse colitis studies, plus cell studies in gut, airway and skin. The evidence is genuinely interesting and genuinely preclinical.
KPV is not approved anywhere. In the US, the FDA moved it off its "do not compound" Category 2 list in April 2026, and in July 2026 its advisory committee voted 8–6 to recommend adding it to the compounding list — for a topical cream, against the advice of FDA's own reviewers, who cited the complete absence of human data. That recommendation is not approval, and KPV is not yet on the list.
Athletes: as a substance with no approval anywhere, KPV falls under WADA S0 (non-approved substances). Prohibited at all times.
- Dalmasso et al., Gastroenterology, 2008 — KPV enters gut and immune cells through the PepT1 transporter; nanomolar doses blocked NF-κB, and KPV in drinking water reduced colitis in mice
- Kannengiesser et al., Inflammatory Bowel Diseases, 2008 — faster recovery and less colon inflammation in two mouse colitis models
- Laroui et al., Gastroenterology, 2010 — oral nanoparticle KPV targeted to the colon matched free KPV's effect at a 12,000-fold lower concentration
- Xiao et al., Molecular Therapy, 2017 — oral hyaluronic-acid nanoparticles carrying KPV sped mucosal healing and lowered TNF-α in mouse colitis
- Viennois et al., Cell Mol Gastroenterol Hepatol, 2016 — KPV prevented colitis-associated tumours in normal mice but not in mice lacking PepT1
- Getting et al., J Pharmacol Exp Ther, 2003 — KPV reduced inflammation in mice without acting through melanocortin receptors
- Land, Int J Physiol Pathophysiol Pharmacol, 2012 — KPV blocked NF-κB entering the nucleus in human airway cells
- Cutuli et al., J Leukocyte Biology, 2000 — alpha-MSH and KPV inhibited Staph aureus and Candida albicans in the lab
- Pawar et al., J Pharm Sciences, 2017 — KPV did not pass through intact human skin by itself
- FDA, Pharmacy Compounding Advisory Committee briefing, July 2026 — no human studies, pharmacokinetic or safety data for KPV by any route
Every peptide batch we sell is tested by Janoshik Analytical, an independent laboratory. Every vial carries an internal AVERON batch code identifying the lot received; each lot is linked to its published Janoshik report. The report carries the manufacturer's submission/task number, not the AVERON code. Ask us or our driver which report covers your code and open it on the laboratory's own website before paying. In our own-driver zone, the team shows you the vial and the report for that batch before payment.
A lab report handed to you by a seller and a lab report you can verify yourself are not the same thing. That's why we publish ours.
View COA on JanoshikMore in Recovery & Resilience


GHK-Cu
Copper peptide for skin, hair and everyday support.








